Our review also revealed negative predictive value in three of four studies that have investigated the predictive significance of K17 in chemotherapy-treated breast and pancreatic cancer and immune checkpoint blockade-treated HNSCC and colorectal cancer. Here, KRT17 is linked to head and neck squamous cell carcinoma.